The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key characteristic
of Parkinson’s disease. To define the nature of the species giving rise to neuronal …
of Parkinson’s disease. To define the nature of the species giving rise to neuronal …
In vivo rate-determining steps of tau seed accumulation in Alzheimer's disease
Both the replication of protein aggregates and their spreading throughout the brain are
implicated in the progression of Alzheimer’s disease (AD). However, the rates of these processes …
implicated in the progression of Alzheimer’s disease (AD). However, the rates of these processes …
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
S Linse, T Scheidt, K Bernfur, M Vendruscolo… - Nature structural & …, 2020 - nature.com
The amyloid cascade hypothesis, according to which the self-assembly of amyloid-β peptide
(Aβ) is a causative process in Alzheimer’s disease, has driven many therapeutic efforts for …
(Aβ) is a causative process in Alzheimer’s disease, has driven many therapeutic efforts for …
Uncovering the universality of self-replication in protein aggregation and its link to disease
Fibrillar protein aggregates are a hallmark of a range of human disorders, from prion
diseases to dementias, but are also encountered in several functional contexts. Yet, the …
diseases to dementias, but are also encountered in several functional contexts. Yet, the …
Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
Transient oligomeric species formed during the aggregation process of the 42-residue form
of the amyloid-β peptide (Aβ 42 ) are key pathogenic agents in Alzheimer’s disease (AD). To …
of the amyloid-β peptide (Aβ 42 ) are key pathogenic agents in Alzheimer’s disease (AD). To …
[HTML][HTML] Interactions of α-synuclein oligomers with lipid membranes
G Musteikytė, AK Jayaram, CK Xu… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Parkinson's disease is an increasingly prevalent and currently incurable neurodegenerative
disorder. At the molecular level, this disease is characterized by the formation of aberrant …
disorder. At the molecular level, this disease is characterized by the formation of aberrant …
N-terminal acetylation of α-synuclein slows down its aggregation process and alters the morphology of the resulting aggregates
Parkinson’s disease is associated with the aberrant aggregation of α-synuclein. Although the
causes of this process are still unclear, post-translational modifications of α-synuclein are …
causes of this process are still unclear, post-translational modifications of α-synuclein are …
[HTML][HTML] Effects of N-terminal acetylation on the aggregation of disease-related α-synuclein variants
…, M Castellana-Cruz, A Nene, RJ Thrush, CK Xu… - Journal of Molecular …, 2023 - Elsevier
Mutations in the SNCA gene, which encodes the protein α-synuclein, have been linked with
early onset Parkinson’s disease. The exact nature of this association, however, is still poorly …
early onset Parkinson’s disease. The exact nature of this association, however, is still poorly …
Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism
The onset and progression of numerous protein misfolding diseases are associated with the
presence of oligomers formed during the aberrant aggregation of several different proteins, …
presence of oligomers formed during the aberrant aggregation of several different proteins, …
Squalamine and its derivatives modulate the aggregation of amyloid-β and α-synuclein and suppress the toxicity of their oligomers
The aberrant aggregation of proteins is a key molecular event in the development and
progression of a wide range of neurodegenerative disorders. We have shown previously that …
progression of a wide range of neurodegenerative disorders. We have shown previously that …
